---
reference_id: "PMID:37973225"
title: Endoscopic Management of Colonic Obstruction.
authors:
- Aboelezz AF
- Othman MO
journal: Gastrointest Endosc Clin N Am
year: '2024'
doi: 10.1016/j.giec.2023.09.011
content_type: abstract_only
---

# Endoscopic Management of Colonic Obstruction.
**Authors:** Aboelezz AF, Othman MO
**Journal:** Gastrointest Endosc Clin N Am (2024)
**DOI:** [10.1016/j.giec.2023.09.011](https://doi.org/10.1016/j.giec.2023.09.011)

## Content

1. Gastrointest Endosc Clin N Am. 2024 Jan;34(1):141-153. doi: 
10.1016/j.giec.2023.09.011. Epub 2023 Oct 13.

Endoscopic Management of Colonic Obstruction.

Aboelezz AF(1), Othman MO(2).

Author information:
(1)Department of Internal Medicine, Gastroenterology and Hepatology Section, 
Faculty of Medicine, Tanta University, El Bahr Street, Tanta Qism 2, Tanta 1, 
Gharbia Governorate 31111, Egypt.
(2)Department of Internal Medicine, Gastroenterology and Hepatology Section, 
Baylor College of Medicine, Gastroenterology Section at Baylor St Luke's Medical 
Center, 7200 Cambridge Street. Suite 8A, Houston, TX 77030, USA. Electronic 
address: Mohamed.othman@bcm.edu.

Large bowel obstruction is a serious event that occurs in approximately 25% of 
all intestinal obstructions. It is attributed to either benign, malignant, 
functional (pseudo-obstruction), or mechanical conditions. Benign etiologies of 
colonic obstructions include colon volvulus, anastomotic strictures, radiation 
injury, ischemia, inflammatory processes such as Crohn's disease, 
diverticulitis, bezoars, and intussusception.

Copyright Â© 2023 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.giec.2023.09.011
PMID: 37973225 [Indexed for MEDLINE]

Conflict of interest statement: Conflict of interest M.O. Othman: M.O. Othman is 
a consultant for Olympus, Boston Scientific Corporation, Abbvie, ConMed, Neptune 
Medical, Creo Medical, Lumendi, and Apollo. MO Othman received research grants 
from Lucid Diagnostics, AbbVie, United States, Nestle, ConMed, United States, 
Olympus and Boston Scientific.